CASE STUDY: REJUVENATING IMPACT OF THE SKIN K PROTOCOL ON FACIAL AGING
PDF
PDF (Portuguese)
HTML

Keywords

Skin K, Skin aging, DMAE (dimethylaminoethanol), Lipofuscin, Oxidative stress, Facial skin firmness, Injectable treatments, Cholinergic modulation

How to Cite

Clauman Goulart , K. . (2026). CASE STUDY: REJUVENATING IMPACT OF THE SKIN K PROTOCOL ON FACIAL AGING. Health and Society, 6(02), 01-14. https://doi.org/10.51249/hs.v6i02.2923

Abstract

Facial aging is a multifactorial process associated with structural changes, reduced muscle tone, increased oxidative stress, and the accumulation of cellular metabolic byproducts, such as lipofuscin, impacting skin firmness, uniformity, and luminosity. In 2018, the author developed an original injectable protocol, called Skin K, with a patent application filed, aiming to promote overall improvement in skin quality and facial support through cellular and neuromuscular modulation. Since its implementation in clinical practice, patients undergoing the protocol have been monitored through comparative clinical evaluation and standardized photographic records. Improvements in tissue firmness, greater homogeneity of skin tone, and an overall rejuvenating appearance were observed. The biological mechanisms involved are discussed based on current literature on skin aging. The findings suggest that the protocol may represent a promising approach for improving skin quality and facial support; however, controlled studies are needed for objective validation of the results and in-depth investigation of the mechanisms involved.

PDF
PDF (Portuguese)
HTML

References

Manso C. Aging and free radicals. Acta Médica Portuguesa. 1992;5:87‑90. Available from: https:// www.actamedicaportuguesa.com/ revista/ index.php/ amp/ article/ download/3197/2536

Braunstein I, Motohashi H, Dallenga T, Schaible UE, Benhar M. Redox signaling in innate immunity and inflammation: focus on macrophages and neutrophils. Free Radic Biol Med. 2025 Sep; 237:427‑454.doi:10.1016/j.freeradbiomed.2025.06.006. :contentReference[oaicite:1]{index=1}

Ferreira ALA, Matsubara LS. Free radicals: concepts, associated diseases, defense system and oxidative stress. Rev Assoc Med Bras. 1997 Jan– Mar;43(1):61– 68. doi:10.1590/ S0104‑42301997000100014. PMID: 9224995.

Mustafa YF. Harmful free radicals in aging: a narrative review of their detrimental effects on health. Indian J Clin Biochem. 2024 Apr;39(2):154–167. doi:10.1007/s12291-023-01147-y. PMID: 38577147. :contentReference[oaicite:1]{index=1}

Renteln M. Toward systemic lipofuscin removal. Rejuvenation Res. 2024 Oct;27(5):171‑179. doi:10.1089/rej.2024.0034. PMID: 39041624. :contentReference[oaicite:1]{index=1}

Moreno‑García A, Kun A, Calero O, Medina M, Calero M. An overview of the role of lipofuscin in age‑related neurodegeneration. Front Neurosci. 2018 Jul 5;12:464. doi:10.3389/ fnins.2018.00464. PMID: 30026686. :contentReference[oaicite:1]{index=1}

Slominski AT, Slominski RM, Raman C, Chen JY, Athar M, Elmets C. Neuroendocrine signaling in the skin with a special focus on the epidermal neuropeptides. Am J Physiol Cell Physiol. 2022 Dec 1;323(6):C1757– C1776. doi:10.1152/ ajpcell.00147.2022. PMID:36317800. :contentReference[oaicite:1]{index=1}

Kurzen H, Schallreuter KU. Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors. Exp Dermatol. 2004;13 Suppl 4:27– 30. doi:10.1111/ j.1600‑0625.2004.00258.x. PMID: 15507109.

Kurzen H. The non‑neuronal cholinergic system of human skin. Skin Physiol. 2007;55(5):453–459. doi:10.1007/s00105‑004‑0724‑5. PMID: 17326008.

Dougnon G, Matsui H. Lipofuscin accumulation in aging and neurodegeneration: a potential “timebomb” overlooked in Alzheimer’s disease. Transl Neurodegener. 2025;14(1):67. doi:10.1186/s40035-025-00529-x. PMID: 41387918.

Baldensperger T, Jung T, Heinze T, Schwerdtle T, Höhn A, Grune T. The age pigment lipofuscin causes oxidative stress, lysosomal dysfunction, and pyroptotic cell death. Free Radic Biol Med. 2024;225:871– 880. doi:10.1016/ j.freeradbiomed.2024.10.311. PMID: 39486751.

Blin O, Audebert C, Pitel S, Kaladjian A, Casse‑Perrot C, Zaim M, et al. Effects of dimethylaminoethanol pyroglutamate (DMAE p‑Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. Psychopharmacology (Berl). 2009 Dec;207(2):201‑212. doi:10.1007/ s00213‑009‑1648‑7. PMID:19756528. :contentReference[oaicite:2]{index=2}

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 Kyze Clauman Goulart